17.01.2013 Views

General information - Eureko Sigorta

General information - Eureko Sigorta

General information - Eureko Sigorta

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

62 EUREKO S‹GORTA<br />

EUREKO S‹GORTA A.fi.<br />

Notes to the Financial Statements As at 31 December 2008<br />

(Currency: New Turkish Lira (TRY))<br />

2.30 New standards and interpretations not yet adopted (continued)<br />

• The amendments to TFRS 1 – First-time Adoption of Turkish Financial Reporting Standards and TAS 27 – Consolidated<br />

and Separate Financial Statements respond to constituents’ concerns that retrospectively determining cost and applying<br />

the cost method in accordance with TAS 27 on first-time adoption of TFRSs cannot, in some circumstances, be achieved<br />

without undue cost or effort. The amendments address that issue:<br />

- by allowing first-time adopters to use a deemed cost of either fair value or the carrying amount under previous<br />

accounting practice to measure the initial cost of investments in subsidiaries, jointly controlled entities and associates<br />

in the separate financial statements; and<br />

- by removing the definition of the cost method from TAS 27 and replacing it with a requirement to present dividends<br />

as income in the separate financial statements of the investor.<br />

The amendments to TAS 27 also respond to queries regarding the initial measurement of cost in the separate financial<br />

statements of a new parent formed as the result of a specific type of reorganisation. The amendments require the new<br />

parent to measure the cost of its investment in the previous parent at the carrying amount of its share of the equity items<br />

of the previous parent at the date of the reorganisation.<br />

The amendment, effective for annual periods beginning on or after 1 January 2009, is not expected to have any impact<br />

on the financial statements of the Company.<br />

• The amendments to TAS 28 – Investments in Associates (and consequential amendments to TAS 32 – Financial<br />

Instruments: Presentation, and TFRS 7 – Financial Instruments: Disclosures) clarify that after applying the equity method,<br />

any additional impairment recognized by the investor with respect to its investment in an associate should not be<br />

allocated to any assets, including goodwill, that constitute the carrying amount of the investment. The amendments<br />

also clarify that reversals of impairment are recorded as an adjustment to the investment balance to the extent that<br />

the recoverable amount of the associate increases. The amendment is effective for annual periods beginning on or<br />

after 1 January 2009, although entities are permitted to adopt them earlier, is not expected to have any impact on<br />

the financial statements of the Company.<br />

• In accordance with the amendments to TAS 27 – Consolidated and Separate Financial Statements, TAS 39 – Financial<br />

Instruments: Recognition and Measurement would continue to be applied where an investment in a subsidiary that<br />

is accounted for under TAS 39, is classified as held for sale under TFRS 5 – Non-Current Assets Held-for-Sale and<br />

Discontinued Operations. The amendment, effective for annual periods beginning on or after 1 January 2009, is not<br />

expected to have any impact on the financial statements of the Company.<br />

• The amendments to TAS 28 – Investments in Associates (and consequential amendments to TAS 32 – Financial<br />

Instruments: Presentation and TFRS 7 – Financial Instruments: Disclosures requires that only certain rather than all<br />

disclosure requirements in TAS 28 need to be made in addition to disclosures required by TAS 32 and TFRS 7, where<br />

an investment in associate is accounted for in accordance with TAS 39 – Financial Instruments: Recognition and<br />

Measurement. The amendment, effective for annual periods beginning on or after 1 January 2009, is not expected<br />

to have any impact on the financial statements of the Company.<br />

• The amendments to TAS 31 – Interests in Joint Ventures (and consequential amendments to TAS 32 – Financial<br />

Instruments: Presentation and TFRS 7 – Financial Instruments: Disclosures requires that only certain rather than all<br />

disclosure requirements in TAS 31 need to be made in addition to disclosures required by TAS 32 and TFRS 7, where<br />

an investment in associate is accounted for in accordance with TAS 39 – Financial Instruments: Recognition and<br />

Measurement. The amendment, effective for annual periods beginning on or after 1 January 2009, is not expected<br />

to have any impact on the financial statements of the Company.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!